Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.

Sexually transmitted diseases - 1 Dec 2002

Ng Lai-King, Sawatzky Pamela, Martin Irene E, Booth Stephanie

Abstract excerpt

BACKGROUND: Ciprofloxacin (500 mg orally, single dose) is one of the recommended therapies for gonorrhea in Canada. In Canada, the first ciprofloxacin-resistant (CipR) Neisseria gonorrhoeae strain was isolated in 1993. Antimicrobial susceptibilities of N gonorrhoeae isolates were monitored as part of a national surveillance program to ensure efficacy of antimicrobial therapies. GOAL: The goal was to determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Canada
Share to Ciprofloxacin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Gyrase

Share to DNA Probes

Share to DNA Topoisomerase IV

Share to Gonorrhea

Share to Neisseria gonorrhoeae

Source

Identifiers

PMID: 12466720
DOI: 10.1097/00007435-200212000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.PMID 12466720Read ↗

Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.Semantic proximity Read ↗

Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.Semantic proximity Read ↗

Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain.Semantic proximity Read ↗

Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines.Semantic proximity Read ↗

Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea.Semantic proximity Read ↗

Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.Semantic proximity Read ↗

Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.Semantic proximity Read ↗

Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.Semantic proximity Read ↗

Exploring quinolone resistance-determining region in Neisseria gonorrhoeae isolates from across India.Semantic proximity Read ↗

Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrheae in India.Semantic proximity Read ↗

The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis.Semantic proximity Read ↗

Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.